Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 12/27/13  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. Thomas X. Neenan

Wrong Dr. Thomas X. Neenan?

Founder and Chief Technology Offi...

Local Address: Boston, Massachusetts, United States
Company Description: Sideris Pharmaceuticals is an independent biopharmaceutical company focused on the development of treatments for diseases of iron overload, including conditions...   more
Background

Employment History

Board Memberships and Affiliations

Education

  • Ph.D. , Synthetic Chemistry
    Penn State University
  • BS , Chemistry and Math
    University College Dublin
10 Total References
Web References
About Sun Biopharma Board Of Directors : Sun BioPharma
www.sunbiopharma.com, 31 Jan 2014 [cached]
Thomas Neenan, Ph.D.
...
Thomas Neenan, Ph.D., Director
Dr. Neenan is an entrepreneur and scientist with extensive chemistry and business development executive experience with Bell Labs, Geltex, Genzyme, Trine Pharma, Warwick Polymers, Gelesis and Proxy Biomedical. Dr. Neenan holds a BS in Chemistry and Math from the University College Dublin in Ireland, a Ph.D. in Synthetic Chemistry from Penn State University, and post-doctoral studies in chemistry at Harvard University. Dr. Neenan also brings a wealth of knowledge to the Company on drug manufacture and was instrumental in improving the synthetic process for SUN-101.
GelTex: Investor Information
www.geltex.com, 27 Sept 2003 [cached]
Thomas X. Neenan, Ph.D. Vice President, Business Operations
"We believe that SP-420 has ...
www.biospace.com, 22 Oct 2013 [cached]
"We believe that SP-420 has the potential to be the best-in-class therapeutic approach for the treatment of transfusion related iron overload," stated Thomas Neenan, PhD, Sideris founder and Chief Technology Officer.
Location | Florida Venture Sourcing
www.floridaventuresourcing.com, 18 Oct 2011 [cached]
"We believe that SP-420 has the potential to be the best-in-class therapeutic approach for the treatment of transfusion related iron overload," stated Thomas Neenan, PhD, Sideris cofounder and Chief Technology Officer.
Press Release
www.mrs.org, 5 April 2000 [cached]
Edited by Thomas Neenan (GelTex Pharmaceuticals, Inc.), Michele Marcolongo (Drexel University) and
Other People with the name "Neenan":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.
zirhbt201304